Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...

HCW Biologics Inc., (NASDAQ: HCWB) began Wednesday trading deep in the red. The Miramar, Fla.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies ...

HCW Biologics ( ($HCWB) ) just unveiled an update. On June 4, 2025, HCW Biologics announced that WY Biotech completed its due diligence on the ...

HCW Biologics earned upfront payment and will recognize revenue of $7.0 million in Q2 2025MIRAMAR, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB ...

MIRAMAR, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical ...

Despite securing a much-needed $5 million lifeline from an equity offering this week, HCW Biologics is continuing to warn that its financial future remains in doubt. The inflammation-focused ...

MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health ...

HCW Biologics Inc. (NASDAQ:HCWB), a pharmaceutical company, is embroiled in legal challenges related to its new headquarters and manufacturing facilities’ construction and renovation.

Shares of HCW Biologics stock opened at $0.28 on Thursday. The firm has a market cap of $12.55 million, a PE ratio of -0.28 and a beta of 0.71. HCW Biologics has a 1 year low of $0.21 and a 1 year ...

MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical ...